seladelpar   Click here for help

GtoPdb Ligand ID: 11137

Synonyms: compound 3r [PMID: 17524639] | Livdelzi® | MBX-8025 | MBX8025
Approved drug PDB Ligand
seladelpar is an approved drug (FDA (2024))
Compound class: Synthetic organic
Comment: Seladelpar (MBX-8025) is a selective PPARδ agonist [3] that was initially developed as a therapy for atherogenic dyslipidemia and nonalcoholic steatohepatitis (NASH).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 90.29
Molecular weight 444.12
XLogP 5.14
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCO[C@H](COc1ccc(cc1)C(F)(F)F)CSc1ccc(c(c1)C)OCC(=O)O
Isomeric SMILES CCO[C@H](COc1ccc(cc1)C(F)(F)F)CSc1ccc(c(c1)C)OCC(=O)O
InChI InChI=1S/C21H23F3O5S/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26/h4-10,17H,3,11-13H2,1-2H3,(H,25,26)/t17-/m1/s1
InChI Key JWHYSEDOYMYMNM-QGZVFWFLSA-N
Selectivity at nuclear hormone receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Peroxisome proliferator-activated receptor-β/δ Primary target of this compound Hs Agonist Agonist 8.7 pEC50 - 3
pEC50 8.7 (EC50 1.9x10-9 M) [3]
Description: Agonist activity determined by cell based transactivation assay.
Peroxisome proliferator-activated receptor-α Hs Agonist Agonist <6.0 pEC50 - 3
pEC50 <6.0 (EC50 >1x10-6 M) [3]
Description: Agonist activity determined by cell based transactivation assay.
Peroxisome proliferator-activated receptor-γ Hs Agonist Agonist <6.0 pEC50 - 3
pEC50 <6.0 (EC50 >1x10-6 M) [3]
Description: Agonist activity determined by cell based transactivation assay.